We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Synairgen Plc | LSE:SNG | London | Ordinary Share | GB00B0381Z20 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 4.65 | 4.52 | 4.99 | - | 189,060 | 10:52:51 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 0 | -17.65M | -0.0876 | -0.53 | 9.36M |
| Date | Subject | Author | Discuss |
|---|---|---|---|
| 31/7/2020 11:52 | I am going for a 220p finish today | dave444 | |
| 31/7/2020 11:12 | I understand that a Phase III trial is usually the trial drug vs The Competition. Since there’s no early-stage competition in C-19 for SNG001, I can’t quite see the point in such a trial. A Phase III in COPD would be a different story. | wetdream | |
| 31/7/2020 11:08 | Are we about to go blue? Real bid 199.75 for 30000 | olly353 | |
| 31/7/2020 11:04 | Could even be some kind of fast track arrangement where phase 3 has to be officially pushed through but there is a gearing up for mass use of the product at the end. This kind of news could allow the share price to soar imho. | allin | |
| 31/7/2020 10:54 | Stage 3 will be bypassed imo. | d1nga | |
| 31/7/2020 10:50 | What will this jump to if trials enter stage 3? | robertreece88 | |
| 31/7/2020 10:43 | And news could arrive anytime. Got to be in to win | d1nga | |
| 31/7/2020 10:34 | This could hang around 200p waiting for news. | allin | |
| 31/7/2020 10:30 | Same MO. . Money goes to the patient. . Hold for the news guys. It is not long to wait. Investing cycle used to be 3-5 years. Why do so many try, and so often fail, to trade.See you next week 250p+ | stoneme |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
